Article
PDX1, a key factor in pancreatic embryogenesis, can exhibit antimetastatic activity in…
Cancer Management and Research · 2019 · Kondratyeva LG, Safina DR, Chernov IP, Kopantzev EP, Kostrov SV, Sverdlov ED
Key facts
| Title | PDX1, a key factor in pancreatic embryogenesis, can exhibit antimetastatic activity in pancreatic ductal adenocarcinoma |
|---|---|
| First author | Kondratyeva LG, Safina DR, Chernov IP, Kopantzev EP, Kostrov SV, Sverdlov ED |
| Journal | Cancer Management and Research |
| Published | Jul 26, 2019 |
| DOI | 10.2147/CMAR.S209940 |
| Devices mentioned | 209940, BK110039, DEN000008, K022086, K071681, K103302, K182886, K810863, K954191, K973350, K982485, K990827 |
| Product codes mentioned | DBM, GKZ, JCI, KIT, LFZ, NDS, NJT, OOI, JLX, KQP, PCA |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1